三管横导管边缘到边缘修复 (T-TEER):对多形病理的单一方法
Alessandro Sticchi1,2,3, Carlo Vitale4, Federico Bargagna4
1University of Pisa, Pisa, Italy. sticchialessandro@gmail.com.
Current cardiology reports
|August 13, 2025
概括
过导管边缘到边缘修复 (T-TEER) 对三管吐有希望,改善生活质量,但不提高死亡率. 新型疗法和优化患者选择可能会改善这种复杂的膜心脏病的结果.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 膜心脏疾病 膜心脏疾病
背景情况:
- 三腹 (TR) 显著影响患有膜心脏病,心力衰竭和肺高血压的患者的发病率和死亡率.
- 多模式成像已经推进了TR表型,有助于患者分层.
研究的目的:
- 审查三腹的跨导管边缘到边缘修复 (T-TEER) 的现状.
- 分析主要T-TEER试验和注册表中的患者表型.
- 讨论TR的药理治疗策略.
主要方法:
- 对TR的T-TEER最近的研究,临床试验和注册表的审查.
- 分析患者数据,包括表型,结果和生活质量.
- 评估新兴的药理疗法,如SGLT2抑制剂.
主要成果:
- T-TEER已经证明了TR严重程度和患者生活质量的改善.
- 在T-TEER之后的死亡结果在当前的试验数据中保持中立.
- 像SGLT2抑制剂这样的新疗法显示出潜力,特别是在心力衰竭患者中.
结论:
- T-TEER是TR的一种有希望的干预选择,但由于疾病异质性和试验与现实世界的人口差异,仍然存在挑战.
- 优化患者选择,整合先进的成像和采用新型药物治疗对于改善临床结果和减少住院治疗至关重要.
- 个性化治疗方法对于管理复杂的三管吐是必不可少的.
相关概念视频
Mitral Regurgitation III: Medical Management
30
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
30
Mitral Stenosis III: Medical Management
21
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
21


